 long term surviv sever rebleed varic sclerotherapi consecut patient cirrhosi esophag varic prospect studi elect sclerotherapi incid extens rebleed mortal rate period studi month mean follow-up period month patient sever rebleed major episod first year patient session sclerosi rebleed probabl rate patient free sever rebleed month pugh classif cent grade percent grade percent grade over-al mortal rate cent patient rate first year mortal rate patient sever kaplan-mei surviv analysi year cent surviv rate relat pugh classif cent cent cent differ group signific high mortal rate patient cirrhosi extens rebleed first year import possibl erad esophag varic